Jan. 15, 2025 – Prostate cancer is quite common – over 60% of those diagnosed are men over the age of 65 – but it’s not a high priority for cancer researchers. One big reason: Most men ...

But after a couple of years of work, xMEMS has arrived at the next generation — ultrasound through a solid-state speaker. This tiny, 1mm-thin speaker is called Cypress, and after listening to it ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...

Howard R. Soule, Ph.D., executive vice president and chief science officer of the Prostate Cancer Foundation, said, "These findings fill a therapeutic gap for patients with advanced prostate cancer.

What is a cystic hygroma? A cystic hygroma — or lymphangioma — is a birth defect that appears as a sac-like structure with a thin wall that most commonly occurs in the head and neck area of an infant.

Chronic inflammation has been observed in human benign prostatic hyperplasia (BPH) tissues, however macrophage activation states and their contributions to this hyperplastic disease have not been ...

Over the past 14 years, clinicians have seen rapid growth in their therapeutic armamentarium to treat advanced prostate cancer. They can now choose among 4 novel second-generation hormone ...

Q: Is it possible to treat prostate cancer with sound waves? A: High-intensity focused ultrasound is an innovative treatment option for men with localized, low to intermediate-risk prostate cancer.